Ligence Heart vs uOmnispace.MR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Ligence Heart

by Ligence

uOmnispace.MR

by Shanghai United Imaging Healthcare Co., Ltd.

AI Verdict

Ligence Heart is an AI-powered platform specifically for automating the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency for cardiologists. In contrast, uOmnispace.MR by Shanghai United Imaging Healthcare Co., Ltd. provides comprehensive AI-powered analysis for magnetic resonance (MR) images, supporting diverse clinical applications including cardiac, brain, and breast imaging. While both offer AI-driven cardiac analysis, their distinct imaging modalities (echocardiography versus MR) mean they address different diagnostic workflows.

Choose Ligence Heart if…

Choose Ligence Heart if your primary need is to significantly enhance the efficiency and accuracy of 2D transthoracic echocardiography analysis. This tool is ideal for cardiology departments seeking to automate view classification, heart phase prediction, and comprehensive measurement calculations, including advanced Doppler and strain, to streamline reporting and improve diagnostic throughput for various cardiac conditions.

View Ligence Heart →

Choose uOmnispace.MR if…

Choose uOmnispace.MR if your clinical practice requires a versatile, AI-powered platform for comprehensive magnetic resonance image analysis across multiple specialties, including neurology, oncology, and cardiology. This tool is best suited for scenarios demanding advanced post-processing, AI-driven segmentation for diverse anatomical regions, MR spectroscopy, perfusion analysis, or the stitching of full-format MR images.

View uOmnispace.MR →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Ligence Heart	uOmnispace.MR
Pricing	Contact-for-pricing	Contact for pricing
Deployment	Cloud-based; on-premise; hybrid	Software-only medical device; can run standalone or integrated with other cleared applications on standard off-the-shelf PCs; supports remote multi-user access on a network. The broader uOmnispace platform is available as SaaS, on-premise, or hybrid.
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Ligence Heart

Ligence Heart (Tool A) is described as a web-based platform that automates echocardiography analysis, aiming to reduce manual work and improve efficiency. This focus on streamlining workflows and automated report generation suggests a highly intuitive and user-friendly experience for its specific application.

Clinical Value

uOmnispace.MR

While both tools are FDA-cleared and offer significant clinical value, uOmnispace.MR (Tool B) provides comprehensive AI-powered MR image analysis across a broader range of clinical applications, including brain, breast, and cardiac imaging. Its advanced features like AI-driven cardiac ventricular segmentation, MR Spectroscopy, and perfusion analysis offer wider diagnostic utility for complex conditions.

Pricing & Value

Tie

Both Ligence Heart (Tool A) and uOmnispace.MR (Tool B) utilize a 'contact for pricing' model, indicating an enterprise-quote structure. Without specific pricing details or public information on their return on investment, it is not possible to definitively compare their value propositions.

Enterprise Readiness

Ligence Heart

Both tools demonstrate strong enterprise readiness with HIPAA compliance, FDA clearance, and BAA availability. However, Ligence Heart (Tool A) explicitly lists integration with existing systems such as PACS, EHR, and RIS, which are critical for seamless adoption within a hospital's IT infrastructure.

Innovation

uOmnispace.MR

Ligence Heart (Tool A) innovates by automating and streamlining echocardiography analysis, including disease recognition. However, uOmnispace.MR (Tool B) showcases a broader application of AI and advanced image processing techniques across multiple, complex MR modalities, including specialized analyses like MR Spectroscopy and perfusion analysis, indicating a higher degree of innovation in diverse and challenging diagnostic areas.

Support & Docs

uOmnispace.MR

While specific details for both tools are limited, Shanghai United Imaging Healthcare Co., Ltd. (Tool B's parent company) is a larger, more established global medical device manufacturer. This typically implies a more extensive and robust customer support infrastructure, comprehensive documentation, and a broader network of resources compared to a more specialized company like Ligence.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Ligence Heart	uOmnispace.MR
Tool Name	Ligence Heart	uOmnispace.MR
Company	Ligence	Shanghai United Imaging Healthcare Co., Ltd.
Primary Imaging Modality	2D transthoracic echocardiography	Magnetic Resonance (MR) image analysis
Key Specialties	Cardiology	Cardiology, Neurology, Radiology
Specific AI Cardiac Features	Automated recognition of echocardiography imaging data, view classification, heart phase prediction, calculation of measurements, report generation, disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases), strain, Spectral and Tissue Doppler measurements	AI-driven cardiac ventricular segmentation, Cardiac function analysis

Videos

Demos, reviews, and walkthroughs featuring Ligence Heart and uOmnispace.MR.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Which imaging modalities are supported by Ligence Heart and uOmnispace.MR?

Ligence Heart is specifically designed for the automated analysis and reporting of 2D transthoracic echocardiography studies. In contrast, uOmnispace.MR is an AI-powered software for comprehensive magnetic resonance (MR) image analysis, supporting various clinical applications including brain, breast, and cardiac imaging.

What specific cardiac analysis features differentiate Ligence Heart from uOmnispace.MR?

Ligence Heart automates view classification, heart phase prediction, measurements (e.g., Area, Distance, Doppler, Volume, Strain), and report generation for echocardiography, including disease recognition for heart failure and valvular heart diseases. uOmnispace.MR offers AI-driven cardiac ventricular segmentation and cardiac function analysis as part of its broader MR image analysis capabilities.

Do these tools offer capabilities beyond cardiology, such as for neurology or radiology?

Ligence Heart is specialized for cardiology, focusing solely on echocardiography analysis. uOmnispace.MR, however, supports diverse clinical applications beyond cardiology, including brain and breast imaging, making it relevant for neurology and radiology in addition to cardiac applications.

How do Ligence Heart and uOmnispace.MR integrate with existing hospital systems?

Ligence Heart offers seamless integration with existing systems such as PACS, EHR, and RIS. uOmnispace.MR can run as a standalone software or integrated with other cleared applications on standard PCs, and its broader uOmnispace platform is available as SaaS, on-premise, or hybrid, supporting remote multi-user access.

How do these tools enhance diagnostic efficiency and automate reporting?

Ligence Heart automates the analysis and reporting of 2D transthoracic echocardiography, including automated view classification, measurements, and report generation, which aims to cut reporting time in half. uOmnispace.MR provides advanced post-processing tools and AI-driven segmentation for MR images, supporting interpretation and evaluation to improve diagnostic workflows.